NO20072830L - Liposomal formel for bortezomib (PS-341) - Google Patents
Liposomal formel for bortezomib (PS-341)Info
- Publication number
- NO20072830L NO20072830L NO20072830A NO20072830A NO20072830L NO 20072830 L NO20072830 L NO 20072830L NO 20072830 A NO20072830 A NO 20072830A NO 20072830 A NO20072830 A NO 20072830A NO 20072830 L NO20072830 L NO 20072830L
- Authority
- NO
- Norway
- Prior art keywords
- liposomes
- bortezomib
- trapped
- boric acid
- liposome
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/69—Boron compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7024—Esters of saccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
- A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Dispersion Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Dermatology (AREA)
- Oncology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US62521604P | 2004-11-05 | 2004-11-05 | |
PCT/US2005/039972 WO2006052733A1 (en) | 2004-11-05 | 2005-11-04 | Liposomal formulation of bortezomib (ps-341) |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20072830L true NO20072830L (no) | 2007-07-24 |
Family
ID=35947260
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20072830A NO20072830L (no) | 2004-11-05 | 2007-06-04 | Liposomal formel for bortezomib (PS-341) |
Country Status (21)
Country | Link |
---|---|
US (2) | US20060159736A1 (es) |
EP (2) | EP1807053A1 (es) |
JP (2) | JP2008519040A (es) |
KR (2) | KR20070085644A (es) |
CN (2) | CN101094649A (es) |
AR (1) | AR051759A1 (es) |
AU (2) | AU2005304881A1 (es) |
BR (2) | BRPI0517668A (es) |
CA (2) | CA2586354A1 (es) |
CR (1) | CR9168A (es) |
EA (1) | EA200701005A1 (es) |
IL (1) | IL182967A0 (es) |
MX (2) | MX2007005499A (es) |
NI (1) | NI200700120A (es) |
NO (1) | NO20072830L (es) |
NZ (2) | NZ554951A (es) |
PE (1) | PE20061135A1 (es) |
TW (1) | TW200618820A (es) |
UY (1) | UY29191A1 (es) |
WO (2) | WO2006052734A1 (es) |
ZA (1) | ZA200705017B (es) |
Families Citing this family (51)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1932517A3 (en) * | 2006-12-11 | 2008-07-16 | Universiteit Utrecht Holding B.V. | Liposomes containing a polyphenol derivative such as caffeic acid and a method of post-loading thereof |
WO2009047639A2 (en) * | 2007-07-23 | 2009-04-16 | Keimyung University Industry Academic Cooperation Foundation | Epicatechin deficient green tea |
US7442830B1 (en) | 2007-08-06 | 2008-10-28 | Millenium Pharmaceuticals, Inc. | Proteasome inhibitors |
EA028622B1 (ru) * | 2007-08-06 | 2017-12-29 | Милленниум Фармасьютикалз, Инк. | Ингибиторы протеасом |
AU2008288920A1 (en) * | 2007-08-21 | 2009-02-26 | Alza Corporation | Liposome formulations of boronic acid compounds |
CA2697042A1 (en) * | 2007-08-21 | 2009-02-26 | Alza Corporation | Liposome compositions for in vivo administration of boronic acid compounds |
NZ624122A (en) | 2008-06-17 | 2015-11-27 | Millennium Pharm Inc | Boronate ester compounds and pharmaceutical compositions thereof |
KR100918776B1 (ko) * | 2009-04-20 | 2009-09-24 | 계명대학교 산학협력단 | 폴리에틸렌 글리콜과 갈레이트 카테킨을 이용한 혈당상승 억제 조성물 |
CN102123698B (zh) | 2008-08-13 | 2016-06-22 | 加利福尼亚技术学院 | 载体纳米颗粒和相关的组合物、方法和系统 |
US8263578B2 (en) | 2010-03-18 | 2012-09-11 | Innopharma, Inc. | Stable bortezomib formulations |
WO2011116286A2 (en) * | 2010-03-18 | 2011-09-22 | Innopharma, Llc | Stable bortezomib formulations |
PT2603514T (pt) | 2010-08-10 | 2018-11-09 | Rempex Pharmaceuticals Inc | Derivados cíclicos de éster de ácido borónico e suas utilizações terapêuticas |
IT1403157B1 (it) | 2010-12-01 | 2013-10-04 | Elbi Int Spa | Macchina lavatrice con rilevazione delle vibrazioni della vasca o camera di lavaggio. |
AU2012223210B2 (en) * | 2011-03-02 | 2016-12-22 | Board Of Regents Of The University Of Texas System | Vesicle compositions |
CN102784114B (zh) * | 2011-05-14 | 2016-03-02 | 山东新时代药业有限公司 | 一种硼替佐米冻干粉针及其制备方法 |
KR20150095809A (ko) | 2012-12-12 | 2015-08-21 | 템플 유니버시티-오브 더 커먼웰쓰 시스템 오브 하이어 에듀케이션 | 암 치료용 조성물 및 방법 |
WO2014107535A1 (en) | 2013-01-04 | 2014-07-10 | Rempex Pharmaceuticals, Inc. | Boronic acid derivatives and therapeutic uses thereof |
US9241947B2 (en) | 2013-01-04 | 2016-01-26 | Rempex Pharmaceuticals, Inc. | Boronic acid derivatives and therapeutic uses thereof |
US9132097B2 (en) | 2013-03-01 | 2015-09-15 | California Institute Of Technology | Nanoparticles stabilized with nitrophenylboronic acid compositions |
US9468681B2 (en) | 2013-03-01 | 2016-10-18 | California Institute Of Technology | Targeted nanoparticles |
US20160129117A1 (en) | 2013-07-03 | 2016-05-12 | Nippon Kayaku Kabushiki Kaisha | Novel Boronic Acid Compound Preparation |
WO2015117136A1 (en) * | 2014-02-03 | 2015-08-06 | Ohio State Innovation Foundation | Boronic acid esters and pharmaceutical formulations thereof |
EP3139930B1 (en) | 2014-05-05 | 2024-08-14 | Melinta Therapeutics, Inc. | Salts and polymorphs of cyclic boronic acid ester derivatives and therapeutic uses thereof |
ES2972939T3 (es) | 2014-05-05 | 2024-06-17 | Melinta Therapeutics Inc | Síntesis de sales de boronato |
CN106459096B (zh) | 2014-05-19 | 2019-03-08 | 莱姆派克斯制药公司 | 硼酸衍生物及其治疗用途 |
TN2016000492A1 (en) | 2014-05-20 | 2018-04-04 | Millennium Pharm Inc | Boron-containing proteasome inhibitors for use after primary cancer therapy. |
MX2016016666A (es) * | 2014-07-01 | 2017-08-08 | Rempex Pharmaceuticals Inc | Derivados de acido boronico y usos terapeuticos de los mismos. |
US10662205B2 (en) | 2014-11-18 | 2020-05-26 | Qpex Biopharma, Inc. | Cyclic boronic acid ester derivatives and therapeutic uses thereof |
WO2016149393A1 (en) | 2015-03-17 | 2016-09-22 | Rempex Pharmaceuticals, Inc. | Boronic acid derivatives and therapeutic uses thereof |
CN107750156B (zh) * | 2015-05-04 | 2020-08-21 | 沃桑缇斯股份公司 | 用于制备跨膜pH梯度囊泡的方法 |
CN108135916B (zh) * | 2015-06-19 | 2022-01-28 | 北京科辉智药生物科技有限责任公司 | 手性特异性含硼化合物及其在治疗癌症或淀粉样变性中的应用 |
US10287401B2 (en) | 2015-07-01 | 2019-05-14 | California Institute Of Technology | Cationic mucic acid polymer-based delivery systems |
CN104958768A (zh) * | 2015-07-17 | 2015-10-07 | 中国科学院长春应用化学研究所 | 一种葡聚糖-硼替佐米键合药及其制备方法 |
US11135309B2 (en) * | 2015-08-14 | 2021-10-05 | The Regents Of The University Of California | Poly(vinyl alcohol) nanocarriers |
WO2018005662A1 (en) | 2016-06-30 | 2018-01-04 | Rempex Pharmaceuticals, Inc. | Boronic acid derivatives and therapeutic uses thereof |
US10583083B1 (en) * | 2016-08-10 | 2020-03-10 | Verily Life Sciences Llc | ROS-responsive multilamellar liposomal vesicles for targeting inflammatory macrophages |
US10517823B1 (en) | 2016-08-10 | 2019-12-31 | Verily Life Sciences Llc | ROS—responsive liposomes for specific targeting |
JP2020500839A (ja) | 2016-10-20 | 2020-01-16 | ファイザー・インク | ペプチドボロン酸またはボロン酸エステル化合物を有する治療用粒子ならびにその作製および使用方法 |
US11964050B2 (en) * | 2017-07-24 | 2024-04-23 | Pharmosa Biopharm Inc. | Liposome compositions comprising weak acid drugs and uses thereof |
BR112020007138B1 (pt) | 2017-10-11 | 2023-03-21 | Qpex Biopharma, Inc | Derivados de ácido borônico, métodos de síntese, composição farmacêutica e uso dos mesmos |
EP3781576B1 (en) | 2018-04-20 | 2024-06-12 | Qpex Biopharma, Inc. | Boronic acid derivatives and therapeutic uses thereof |
CN110540547A (zh) * | 2018-05-28 | 2019-12-06 | 秦艳茹 | 一种肽硼酸酯类化合物的合成与用途 |
JP7483193B2 (ja) | 2018-06-13 | 2024-05-15 | カリフォルニア・インスティテュート・オブ・テクノロジー | 血脳バリアを越えるためのナノ粒子とそれを用いた治療法 |
CN109045272A (zh) * | 2018-08-01 | 2018-12-21 | 厦门市壳聚糖生物科技有限公司 | 一种硼替佐米磷脂复合物及其制备方法与应用 |
BR112021021875A2 (pt) * | 2019-05-14 | 2021-12-28 | Pharmosa Biopharm Inc | Composição farmacêutica e método de tratamento de hipertensão pulmonar |
EP4041246A4 (en) * | 2019-10-07 | 2023-11-01 | Cornell University | ANTIMICROBIAL AND ANTIVIRAL EFFECTS OF ALKYL-BORONIC ACIDS C2-C7 |
WO2022182993A1 (en) * | 2021-02-25 | 2022-09-01 | Ohio State Innovation Foundation | Liposomal formulations of boronic acid containing active agents |
CN112915094A (zh) * | 2021-03-26 | 2021-06-08 | 东南大学 | 一种硼替佐米脂质体制剂的制备方法 |
WO2023220641A2 (en) | 2022-05-11 | 2023-11-16 | Juno Therapeutics, Inc. | Methods and uses related to t cell therapy and production of same |
WO2023220655A1 (en) | 2022-05-11 | 2023-11-16 | Celgene Corporation | Methods to overcome drug resistance by re-sensitizing cancer cells to treatment with a prior therapy via treatment with a t cell therapy |
WO2024097905A1 (en) | 2022-11-02 | 2024-05-10 | Celgene Corporation | Methods of treatment with t cell therapy and immunomodulatory agent maintenance therapy |
Family Cites Families (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5736155A (en) * | 1984-08-08 | 1998-04-07 | The Liposome Company, Inc. | Encapsulation of antineoplastic agents in liposomes |
US5077056A (en) * | 1984-08-08 | 1991-12-31 | The Liposome Company, Inc. | Encapsulation of antineoplastic agents in liposomes |
US4885172A (en) * | 1985-06-26 | 1989-12-05 | The Liposome Company, Inc. | Composition for targeting, storing and loading of liposomes |
US5047245A (en) * | 1985-07-26 | 1991-09-10 | The Liposome Company, Inc. | Novel composition for targeting, storing and loading of liposomes |
US5252263A (en) * | 1986-06-16 | 1993-10-12 | The Liposome Company, Inc. | Induction of asymmetry in vesicles |
IL91664A (en) * | 1988-09-28 | 1993-05-13 | Yissum Res Dev Co | Ammonium transmembrane gradient system for efficient loading of liposomes with amphipathic drugs and their controlled release |
US6132763A (en) * | 1988-10-20 | 2000-10-17 | Polymasc Pharmaceuticals Plc | Liposomes |
US5013556A (en) * | 1989-10-20 | 1991-05-07 | Liposome Technology, Inc. | Liposomes with enhanced circulation time |
US5620689A (en) * | 1989-10-20 | 1997-04-15 | Sequus Pharmaceuuticals, Inc. | Liposomes for treatment of B-cell and T-cell disorders |
EP0555229B1 (en) * | 1990-07-31 | 1996-06-05 | The Liposome Company, Inc. | Accumulation of amino acids and peptides into liposomes |
US5395619A (en) * | 1993-03-03 | 1995-03-07 | Liposome Technology, Inc. | Lipid-polymer conjugates and liposomes |
US6326353B1 (en) * | 1993-03-23 | 2001-12-04 | Sequus Pharmaceuticals, Inc. | Enhanced circulation effector composition and method |
US6180134B1 (en) * | 1993-03-23 | 2001-01-30 | Sequus Pharmaceuticals, Inc. | Enhanced ciruclation effector composition and method |
US6083903A (en) * | 1994-10-28 | 2000-07-04 | Leukosite, Inc. | Boronic ester and acid compounds, synthesis and uses |
US6214388B1 (en) * | 1994-11-09 | 2001-04-10 | The Regents Of The University Of California | Immunoliposomes that optimize internalization into target cells |
US5972379A (en) * | 1995-02-14 | 1999-10-26 | Sequus Pharmaceuticals, Inc. | Liposome composition and method for administering a quinolone |
WO1996032930A1 (en) * | 1995-04-18 | 1996-10-24 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Liposome drug-loading method and composition |
EP0932390A1 (en) * | 1996-10-11 | 1999-08-04 | Sequus Pharmaceuticals, Inc. | Therapeutic liposome composition and method |
US6056973A (en) * | 1996-10-11 | 2000-05-02 | Sequus Pharmaceuticals, Inc. | Therapeutic liposome composition and method of preparation |
US6224903B1 (en) * | 1996-10-11 | 2001-05-01 | Sequus Pharmaceuticals, Inc. | Polymer-lipid conjugate for fusion of target membranes |
WO1998017256A1 (en) * | 1996-10-22 | 1998-04-30 | Dmitri Kirpotin | Compound-loaded liposomes and methods for their preparation |
US6831057B2 (en) * | 1997-10-28 | 2004-12-14 | The University Of North Carolina At Chapel Hill | Use of NF-κB inhibition in combination therapy for cancer |
US6051251A (en) * | 1997-11-20 | 2000-04-18 | Alza Corporation | Liposome loading method using a boronic acid compound |
BR9914601A (pt) * | 1998-09-16 | 2001-10-23 | Alza Corp | Inibidor de topoisomerase capturado por lipossoma |
KR20070086708A (ko) * | 1999-07-14 | 2007-08-27 | 알자 코포레이션 | 중성 지질중합체 및 그를 함유하는 리포솜 조성물 |
WO2001035966A1 (en) * | 1999-11-19 | 2001-05-25 | Topgene, Inc. | Boron compounds and complexes as anti-inflammatory agents |
CA2435146C (en) * | 2001-01-25 | 2011-03-29 | The United States Of America, Represented By The Secretary, Department Of Health And Human Services | Formulation of boronic acid compounds |
US20060084592A1 (en) * | 2002-09-09 | 2006-04-20 | Trigen Limited | Peptide boronic acid inhibitors |
AU2003291356A1 (en) * | 2002-11-06 | 2004-06-03 | Dana-Farber Cancer Institute, Inc. | Methods and compositions for treating cancer using proteasome inhibitors |
-
2005
- 2005-10-25 TW TW094137236A patent/TW200618820A/zh unknown
- 2005-11-02 PE PE2005001284A patent/PE20061135A1/es not_active Application Discontinuation
- 2005-11-04 EP EP05824137A patent/EP1807053A1/en not_active Withdrawn
- 2005-11-04 UY UY29191A patent/UY29191A1/es unknown
- 2005-11-04 MX MX2007005499A patent/MX2007005499A/es unknown
- 2005-11-04 EP EP05821699A patent/EP1807052A1/en not_active Withdrawn
- 2005-11-04 CN CNA2005800457618A patent/CN101094649A/zh active Pending
- 2005-11-04 CN CNA2005800457552A patent/CN101094648A/zh active Pending
- 2005-11-04 BR BRPI0517668-9A patent/BRPI0517668A/pt not_active IP Right Cessation
- 2005-11-04 NZ NZ554951A patent/NZ554951A/en not_active IP Right Cessation
- 2005-11-04 CA CA002586354A patent/CA2586354A1/en not_active Abandoned
- 2005-11-04 WO PCT/US2005/039973 patent/WO2006052734A1/en active Application Filing
- 2005-11-04 EA EA200701005A patent/EA200701005A1/ru unknown
- 2005-11-04 KR KR1020077012434A patent/KR20070085644A/ko not_active Application Discontinuation
- 2005-11-04 CA CA002586348A patent/CA2586348A1/en not_active Abandoned
- 2005-11-04 AR ARP050104638A patent/AR051759A1/es unknown
- 2005-11-04 US US11/267,076 patent/US20060159736A1/en not_active Abandoned
- 2005-11-04 BR BRPI0517061-3A patent/BRPI0517061A/pt not_active IP Right Cessation
- 2005-11-04 WO PCT/US2005/039972 patent/WO2006052733A1/en active Application Filing
- 2005-11-04 JP JP2007540070A patent/JP2008519040A/ja not_active Withdrawn
- 2005-11-04 US US11/267,794 patent/US20060153907A1/en not_active Abandoned
- 2005-11-04 AU AU2005304881A patent/AU2005304881A1/en not_active Abandoned
- 2005-11-04 MX MX2007005497A patent/MX2007005497A/es unknown
- 2005-11-04 KR KR1020077012432A patent/KR20070085642A/ko not_active Application Discontinuation
- 2005-11-04 AU AU2005304880A patent/AU2005304880A1/en not_active Abandoned
- 2005-11-04 NZ NZ554950A patent/NZ554950A/en not_active IP Right Cessation
- 2005-11-04 JP JP2007540071A patent/JP2008519041A/ja not_active Withdrawn
-
2007
- 2007-05-03 IL IL182967A patent/IL182967A0/en unknown
- 2007-05-04 NI NI200700120A patent/NI200700120A/es unknown
- 2007-06-04 ZA ZA200705017A patent/ZA200705017B/xx unknown
- 2007-06-04 NO NO20072830A patent/NO20072830L/no not_active Application Discontinuation
- 2007-06-05 CR CR9168A patent/CR9168A/es not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
EA200701005A1 (ru) | 2007-10-26 |
CR9168A (es) | 2008-11-24 |
WO2006052734A1 (en) | 2006-05-18 |
NZ554951A (en) | 2010-12-24 |
KR20070085642A (ko) | 2007-08-27 |
EP1807053A1 (en) | 2007-07-18 |
US20060159736A1 (en) | 2006-07-20 |
CN101094649A (zh) | 2007-12-26 |
CA2586354A1 (en) | 2006-05-18 |
KR20070085644A (ko) | 2007-08-27 |
NI200700120A (es) | 2008-05-15 |
TW200618820A (en) | 2006-06-16 |
JP2008519040A (ja) | 2008-06-05 |
AR051759A1 (es) | 2007-02-07 |
WO2006052733A1 (en) | 2006-05-18 |
MX2007005497A (es) | 2007-09-21 |
CN101094648A (zh) | 2007-12-26 |
BRPI0517061A (pt) | 2008-09-30 |
AU2005304880A1 (en) | 2006-05-18 |
AU2005304881A1 (en) | 2006-05-18 |
ZA200705017B (en) | 2008-09-25 |
MX2007005499A (es) | 2007-09-21 |
US20060153907A1 (en) | 2006-07-13 |
IL182967A0 (en) | 2007-08-19 |
CA2586348A1 (en) | 2006-05-18 |
NZ554950A (en) | 2010-12-24 |
UY29191A1 (es) | 2006-01-31 |
PE20061135A1 (es) | 2006-10-20 |
EP1807052A1 (en) | 2007-07-18 |
JP2008519041A (ja) | 2008-06-05 |
BRPI0517668A (pt) | 2008-10-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20072830L (no) | Liposomal formel for bortezomib (PS-341) | |
CR20110324A (es) | ANTICUERPO ANTI-cMET NOVEDOSO | |
WO2006132959A3 (en) | Inhibition of thrombin generation | |
SE0301888D0 (sv) | New use VII | |
SE0301882D0 (sv) | New use I | |
SE0301886D0 (sv) | New use V | |
WO2008066887A3 (en) | Small molecule inhibitors of bcl6 | |
NI201000030A (es) | Formulaciones de liposomas de compuestos de ácidos borónico | |
EP1829863A4 (en) | ARYLALCANOIC ACID DERIVATIVE | |
WO2005054179A3 (en) | Hydroxamic acid esters and pharmaceutical use thereof | |
MY143568A (en) | 11b-hsd1 inhibitors for the treatment of diabetes | |
WO2009018219A3 (en) | Methods and compositions for modulating rad51 and homologous recombination | |
WO2009156735A3 (en) | New therapeutic agents | |
WO2006094144A3 (en) | Use of rifaximin for the prevention of aspiration pneumonia and/or sepsis | |
PE20060425A1 (es) | Formulacion de tableta revestida que comprende saxagliptina | |
WO2010009892A8 (en) | Compositions for the treatment of pain and/or inflamation | |
CA2478374A1 (en) | N3 alkylated benzimidazole derivatives as mek inhibitors | |
GEP20094720B (en) | Pyrido[2,3-d]pyrimidine-2,4-diamines as pde 2 inhibitors | |
RU2012130405A (ru) | Хальконы в качестве усилителей антимикробных средств | |
NI200800175A (es) | Uso de derivados de sulfamidas heterocíclicas benzo-fusionadas para el tratamiento de abuso y adicción de sustancias. | |
UA101044C2 (ru) | Композиция для местного применения для лечения актинического кератоза | |
BR0314450A (pt) | Sais de ácido borÈnico com adição de uma base farmaceuticamente aceitável, formulação farmacêutica, e uso dos referidos sais para preparar uma formulação farmacêutica | |
WO2005123192A3 (en) | Improving pain treatment with strontium combinations | |
MX2013009245A (es) | Composicion antifungica novedosa. | |
CY1115629T1 (el) | Χρηση ενωσεων πεπτιδιου τρο και φαρμακευτικων συνθεσεων στην θεραπεια της αναιμιας |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |